| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 39 |
| 1 | TACROLIMUS | 25 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 23 |
| 3 | TACROLIMUS OINTMENT 0.1% | 23 |
| 4 | LISINOPRIL | 20 |
| 5 | METHYLPREDNISOLONE | 20 |
| 6 | ASPIRIN | 19 |
| 7 | GABAPENTIN | 19 |
| 8 | OMEPRAZOLE MAGNESIUM | 19 |
| 9 | ASPIRIN 325 MG | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 1 | LOMUSTINE | 3 | 0.0012 |
| 2 | RYDAPT | 2 | 0.0010 |
| 3 | FOSCARNET SODIUM | 4 | 0.0010 |
| 4 | CEFEPIME HYDROCHLORIDE | 16 | 0.0010 |
| 5 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| 6 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 7 | CARMUSTINE | 4 | 0.0008 |
| 8 | CEFACLOR | 1 | 0.0006 |
| 9 | DAPTOMYCIN | 6 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | Loop Diuretic [EPC] | 44 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 43 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 26 |
| 4 | Proton Pump Inhibitor [EPC] | 24 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 6 | Platinum-based Drug [EPC] | 19 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 15 |
| 9 | beta-Adrenergic Blocker [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipopeptide Antibacterial [EPC] | 6 | 0.0006 |
| 1 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 7 | 0.0005 |
| 3 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 4 | Anthelmintic [EPC] | 1 | 0.0003 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 7 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 8 | Penem Antibacterial [EPC] | 9 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |